nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antibody therapy for residual disease in acute myelogenous leukemia
|
Jurcic, Joseph G. |
|
2001 |
38 |
1 |
p. 37-45 9 p. |
artikel |
2 |
Development of ABX-EGF, a fully human anti-EGF receptor monoclonal antibody, for cancer therapy
|
Yang, Xiao-Dong |
|
2001 |
38 |
1 |
p. 17-23 7 p. |
artikel |
3 |
Development of a minimally immunogenic variant of humanized anti-carcinoma monoclonal antibody CC49
|
Kashmiri, S.V.S. |
|
2001 |
38 |
1 |
p. 3-16 14 p. |
artikel |
4 |
Differentiated thyroid carcinoma in the elderly
|
van Tol, K.M. |
|
2001 |
38 |
1 |
p. 79-91 13 p. |
artikel |
5 |
Internet pharmaco-economic studies in metastatic colorectal cancer
|
Launois, R. |
|
2001 |
38 |
1 |
p. 63-77 15 p. |
artikel |
6 |
Preclinical and clinical data with bispecific antibodies recruiting myeloid effector cells for tumor therapy
|
van Ojik, H.H |
|
2001 |
38 |
1 |
p. 47-61 15 p. |
artikel |
7 |
Systemic radiotherapy in metastatic breast cancer using 90Y-linked monoclonal MUC-1 antibodies
|
Richman, Carol M |
|
2001 |
38 |
1 |
p. 25-35 11 p. |
artikel |
8 |
The promise of monoclonal antibodies for the therapy of cancer
|
Gutheil, John |
|
2001 |
38 |
1 |
p. 1-2 2 p. |
artikel |